Cognitive Function in Athletes Cleared for Return-to-Play After Sport-Related Concussion (Cog-RTP)
Cognitive Function in Athletes Cleared for Return-to-Play After Sport-Related Concussion (Cog-RTP)
The purpose of this study is to determine whether a brief, objective cognitive assessment can detect exercise-induced changes in cognitive performance in adolescent athletes who have been medically cleared for return-to-play following sport-related concussion.
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Kayla Covert, DPT
- Telefonnummer: 2146031527
- E-post: Kayla.Covert@BSWHealth.org
Studiesteder
-
-
Texas
-
Frisco, Texas, Forente stater, 75034
- Baylor Scott & White Sports Therapy & Research at the Star
-
Ta kontakt med:
- Kayla Covert, DPT
- E-post: Kayla.Covert@BSWHealth.org
-
Hovedetterforsker:
- Kayla Covert, DPT
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- 12-18 years old
- Actively engaged in organized sports activities within the past 12 months
- Completed RTP (Return-to-Play) testing within the past 30 days
Exclusion Criteria:
- History of ocular or muscular spasms
- History of epileptic seizures
- History of fainting or loss of consciousness triggered by flashes of light, patterns, or exposure to infrared light sources (e.g., eye tracker)
- History of eye surgery and lenses implanted with different prescriptions in each eye
- History of ptosis (drooping eyelids)
- Taking medications that cause pupil dilation
- Active concussion symptoms
- Cardiovascular, respiratory, or neurological conditions contraindicating exertion
- Orthopedic or neurologic, or other limitations
- History of moderate or severe traumatic brain injury (GCS ≤12)
- Uncontrolled asthma
- Limited English proficiency
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Screening
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: Adolescents following medical clearance from concussion
|
Participants will undergo a supervised, 30-minute, moderate-intensity, bodyweight workout with a warm-up and a cool down. |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Cognitive performance
Tidsramme: Baseline (pre-exercise) and immediately post-exercise during the single study visit
|
Cognitive performance measured before and immediately after standardized exercise during a single study visit. Cognitive domains assessed include Processing Speed, Executive Function, Working Memory, Short-Term Memory, Sustained Attention, Selective Attention, and Spatial Perception. |
Baseline (pre-exercise) and immediately post-exercise during the single study visit
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Rivermead Post Concussion Questionnaire 3 (RPQ-3)
Tidsramme: baseline, pre-intervention
|
The RPQ-3 assesses the severity of three post-concussion symptoms: headache, dizziness, and nausea. Each item is scored on a scale of 0-4, with a total score ranging from 0 to 12. Higher scores indicate greater post-concussion symptom severity (worse outcomes). |
baseline, pre-intervention
|
|
Pediatric Quality of Life Inventory Short Form 15 (PedsQL 4.0 SF-15)
Tidsramme: baseline, pre-intervention
|
The PedsQL 4.0 SF-15 assesses health-related quality of life in children and adolescents across four domains: physical functioning, emotional functioning, social functioning, and school functioning. The 15 items are rated on a 5-point Likert scale (0-4) and reverse-scored and linearly transformed to a 0-100 scale. The total score ranges from 0 to 100, with higher scores indicating better health-related quality of life (better outcomes). |
baseline, pre-intervention
|
|
Brief Pittsburgh Sleep Quality Index (B-PSQI)
Tidsramme: baseline, pre-intervention
|
The B-PSQI assesses sleep quality over the past month across seven domains: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. The six items are scored on a scale of 0-3, with a total score ranging from 0 to 18. Higher scores indicate poorer sleep quality (worse outcomes). |
baseline, pre-intervention
|
|
Vestibular/Oculomotor Motor Screening (VOMS)
Tidsramme: baseline, pre-intervention
|
The VOMS assesses vestibular and ocular motor symptom provocation following concussion. The assessment includes smooth pursuits, horizontal and vertical saccades, near point of convergence, vestibulo-ocular reflex (VOR), and visual motion sensitivity (VMS). Participants rate four symptoms (headache, dizziness, nausea, and fogginess) on a scale of 0-10 before and immediately after each task. The total symptom score ranges from 0 to 280, with higher scores indicating greater symptom severity (worse outcomes). Symptom provocation is also assessed by calculating the change in symptom ratings from baseline. |
baseline, pre-intervention
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Hjerneskader, traumatiske
- Hjernesykdommer
- Sykdommer i sentralnervesystemet
- Sykdommer i nervesystemet
- Sår og skader
- Kraniocerebralt traume
- Traumer, nervesystemet
- Hodeskader, stengt
- Sår, ikke-penetrerende
- Hjerneskader
- Hjernerystelse
- Motorisk aktivitet
- Bevegelse
- Muskel- og skjelettfysiologiske fenomener
- Muskel- og skjelett og nevrale fysiologiske fenomener
- Øvelse
Andre studie-ID-numre
Andre studie-ID-numre
- 026-373
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Aggregated and anonymized study findings will be reported in scientific publications. De-identified data will be shared with collaborators as specified in data use agreements after institutional review and approval.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .